Urologist, Calgary Health Region
Clinical Associate Professor, University of Calgary
Co-Founder & Chairman, Prostate Cancer Institute, Calgary
Dr. Donnelly is a staff Urologist at the Calgary Health Region and. He is a Clinical Associate Professor at the University of Calgary and is Co-founder and Chairman of the Prostate Cancer Institute in Calgary. Dr. Donnelly took his Urology training in Dublin, Ireland and also Edmonton, Alberta where he completed an M.Sc. His area of special interest is Prostate Cancer, and is an internationally recognized authority on the role of cryosurgery in this field. With Dr. Don Metcalfe, he introduced laparoscopic to Alberta.
He initiated the rapid access clinic at the Calgary Prostate Center, and the Educational forums for newly diagnosed patients. He runs the clinical trials unit at the prostate center. More recently, he is examining the role of cryosurgery in treatment of kidney cancer. He serves, and has served on many provincial, national, and international committees in urology, and is co-chair of the Alberta Prostate Cancer research consortium.
Relevant Publications
Flannigan RK, Gotto GT, Donnelly B, Carlson KV. Standardized follow-up program may reduce emergency room and urgent care visits for patients undergoing radical prostatectomy. Can Urol Assoc J. 2014 Jul;8(7-8):E505-9.
Huang KC, Alshalalfa M, Hegazy SA, Dolph M, Donnelly B, Bismar TA. The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy. Cancer Biol Ther. 2014 Sep 1;15(9):1120-8.
Huang KC, Dolph M, Donnelly B, Bismar TA. ERG expression is associated with increased risk of biochemical relapse following radical prostatectomy in early onset prostate cancer. Clin Transl Oncol. 2014 May 6.
Teng LH, Wang C, Bégin LR, Dolph M, Yilmaz A, Trpkov K, Donnelly B, Bismar TA. ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease. Urology. 2013 Aug;82(2):394-9.
Bismar TA, Dolph M, Teng LH, Liu S, Donnelly B. ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality. Eur J Cancer. 2012 Mar;48(4):538-46.
Allan GM, Chetner MP, Donnelly BJ, Hagen NA, Ross D, Ruether JD, Venner. Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks). Can Urol Assoc J. 2011 Dec;5(6):416-21.
Thirukkumaran CM, Nodwell MJ, Hirasawa K, Shi ZQ, Diaz R, Luider J, Johnston RN, Forsyth PA, Magliocco AM, Lee P, Nishikawa S, Donnelly B, Coffey M, Trpkov K, Fonseca K, Spurrell J, Morris DG. Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res. 2010 Mar 15;70(6):2435-44.
Robinson JW, Donnelly BJ, Siever JE, Saliken JC, Ernst SD, Rewcastle JC, Trpkov K, Lau H, Scott C, Thomas B.A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes. Cancer. 2009 Oct 15;115(20):4695-704.
Kavanagh AG, Lee JC, Donnelly B. Time to treatment of prostate cancer through the Calgary Prostate Institute rapid access clinic. Can J Urol. 2008 Apr;15(2):3975-9.
Robinson JW, Donnelly BJ, Coupland K, Siever JE, Saliken JC, Scott C, Brasher PM, Ernst DS.Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urol Oncol. 2006 Nov-Dec;24(6):472-86.
Donnelly BJ, Saliken JC, Ernst DS, Weber B, Robinson JW, Brasher PM, Rose M, Rewcastle J.Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis. 2005;8(3):235-42.
Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW, Rewcastle JC.Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002 Oct;60(4):645-9.
Saliken JC, Donnelly BJ, Rewcastle JC. The evolution and state of modern technology for prostate cryosurgery. Urology. 2002 Aug;60(2 Suppl 1):26-33. Review.
Saliken JC, Donnelly BJ, Ernst S, Rewcastle J. Prostate Cryotherapy: practicalities and applications following from the Calgary experience. Can Assoc Radio J; 2001;52(3): 165-173
Rewcastle JC, Sandison GA, Hahn LJ, Saliken JC, McKinnon JG, Donnelly BJ. A model for the time-dependent thennal distribution within an iceball surrounding a cryoprobe. Phys Med Bioi. 1998 Dec; 43(12):3519-34.
Sandison GA, Loye MP, Rewcastle JC, Hahn LJ, Saliken JC, McKinnon JG, Donnelly BJ. X-ray CT monitoring oficeball growth and thennal distribution during cryosurgery. Phys Med Bioi. 1998 Nov; 43(11):3309-24.
Steed J, Saliken JC, Donnelly BJ, AliRidha NH. Correlation between thennosensor temperature and transrectal ultrasonography during prostate cryoablation. Can Assoc Radiol J. 1997 Jun; 48(3):186-90.
Vellet AD, Saliken J, Donnelly B, Raber E, McLaughlin RF, Wiseman D, Ali-Ridha NH. Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications. Radiology. 1997 Jun; 203(3):653-9.